Status:
COMPLETED
Changes in Breast 3D Ultrasound Measurements Using Toremifene
Lead Sponsor:
Satakunta Central Hospital
Collaborating Sponsors:
Tampere University Hospital
Tampere University
Conditions:
Circulatory; Change
Eligibility:
FEMALE
25-45 years
Phase:
PHASE3
Brief Summary
To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.
Detailed Description
20 women were participated to this trial.
Eligibility Criteria
Inclusion
- age 25-45 healthy person
- regular menstrual cycles
- safe contraception(for example sterilization or condom)
Exclusion
- gynecological or other type of cancer
- hormonal contraception
- pregnancy
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01417754
Start Date
September 1 2010
End Date
June 1 2011
Last Update
August 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Porin Lääkäritalo
Pori, Finland, 28100